Code Kenneth Reay reported gift involving 2,000,000 shares of BIOLARGO, INC. at $0.00 for $0 on Sep 30, 2026

Gift
Form 4 code G. Bona fide gift.
Chief Science Officer
Chief Science Officer
Filed Oct 2, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
2,000,000Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
24,974,580Direct
Trade date
Sep 30, 2026Gift
Filed
Oct 2, 2026, 7:32 PM ET2-day reporting delay
Accession
0001437749-26-031944Code G · Transaction 235985
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Sep 30, 2026Grant566,261$0.08$45,300.88Trade 235984
2 transaction rows in this filing. Joint filers share the same rows.

BLGO price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
BLGO · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Oct 9, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: The shares acquired are subject to a Lock-Up Agreement dated as of the issuance date whereby shares are locked-up and restricted from sale until the Issuer reports gross revenue of at least $40 million on a consolidated basis for any reported period (e.g, quarter or annual), or the Issuer's market capitalization exceeds $300 million, or there is a "change in control" in the Issuer. F2: Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares acquired and the acquisition price per share). F3: Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.